Diane Côté
President & CEO @ MEDTEQ+
Montréal, Canada
Diane Côté is a grant investor at MEDTEQ+ in Montréal focused on Health Care and Biotechnology. Diane Côté
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Diane Côté invests in
Stages Diane Côté invests in
Countries Diane Côté invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BioMark Diagnostics
|
BioMark is an oncology-focused company with advanced near-to- market diagnostic technologies designed to improve patient outcomes. They have developed and own multiple intellectual properties (IPs) in detection and quantitation of metabolites.They hand-picked a proven, global enterprise team of scientists, engineers and medical professionals tohelp commercialize their innovative technology and to increase prediction and accuracy in the diagnosis of cancers by following and incorporating the highest regulatory ,clinical and scientific standards.. Their cross pollinated, balanced and committed team was established in 2007. Their mission is to develop and commercialize innovative technologies to increase prediction and accuracy in diagnosis of cancers. | $683.4K / Grant / Jun 01, 2021 |
Co-Investors
About MEDTEQ+
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
MEDTEQ+ Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Diane Côté
President & CEO
|
|||
|
Jacques Milette
Président sortant du CA, MEDTEQ+
|
|||
Meryeme Lahmami
Investment manager
|
|||
Robert Ritlop
Director of Investments
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Diane Côté invest in?
Diane Côté invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Diane Côté last invest?
The most recent investment recorded for Diane Côté closed in Jun 2021. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
